6 completed. 6 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 6 |
| Phase 1 | 2 | Completed 2 |
Follow Sneezing: new trials by email Literature Review of Sneezing trials Research Report on Sneezing
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination Study Of S-555739/Cetirizine HCl In Adult Patients With Seasonal Allergic Rhinitis S-555739 Dose 1, S-555739 Dose 2, Cetirizine HCl Dose 1 - Seasonal Allergic Rhinitis | Phase 2 | Completed | Shionogi | 779 | 2012-07-01 | 2018-04-27 |
| Effects of AkPharma's Calcium Glycerophosphate Nasal Spray Wash Calcium Glycerophosphate Nasal Spray Wash - Allergic Rhinitis | Phase 1 / Phase 2 | Completed | Drexel University | 17 | 2012-05-01 | 2015-05-25 |
| Pharmacokinetic Study of Bilastine in Children From 2 to < 12 Years of Age With Either Allergic Rhinoconjunctivitis (AR) or Chronic Urticaria (CU) Bilastine - Allergic Rhinoconjunctivitis, Chronic Urticaria | Phase 1 / Phase 2 | Completed | Faes Farma, S.A. | 36 | 2010-01-01 | 2012-09-26 |
| A Randomized, Double-blind, Placebo-controlled Study on the Effect of CVT-E002 in Patients With Seasonal Allergic Rhinitis COLD-fX, Placebo - Seasonal Allergic Rhinitis | Phase 2 | Completed | Afexa Life Sciences Inc | 200 | 2008-05-01 | 2010-10-11 |
| Assess the Efficacy and Safety of Rhinocort Aqua Budesonide, Placebo - Allergic Rhinitis | Phase 2 | Completed | AstraZeneca | 650 | 2004-04-01 | 2011-01-24 |
| New Nasal Applicator / New Formulation - User Study budesonide, Budesonide, Placebo - Seasonal Allergic Rhinitis | Phase 2 | Completed | AstraZeneca | 200 | 2002-04-01 | 2011-01-24 |
Rhinitis, Allergic (4) · Rhinitis, Allergic, Seasonal (4) · Nasal Obstruction (3) · Rhinorrhea (3) · Hypersensitivity (2) · Pruritus (2) · Rhinitis (2) · Chronic Urticaria (1) · Erythema (1) · Rhinitis, Allergic, Perennial (1) · Urticaria (1)
Hypersensitivity, Immediate (6) · Immune System Diseases (6) · Nose Diseases (6) · Otorhinolaryngologic Diseases (6) · Pathological Conditions, Signs and Symptoms (6) · Respiratory Hypersensitivity (6) · Respiratory Tract Diseases (6) · Signs and Symptoms (6) · Signs and Symptoms, Respiratory (6) · Hypersensitivity (4) · Rhinitis (4) · Airway Obstruction (3) · Respiration Disorders (3) · Respiratory Insufficiency (3) · Infections (2)
Budesonide (2) · COLD-fX (1) · bilastine (1)
AstraZeneca (2) · Afexa Life Sciences Inc (1) · Drexel University (1) · Faes Farma, S.A. (1) · Shionogi (1)
Australia (1) · Canada (1) · Germany (1) · Sweden (1) · United States (1)
Bertil Andersson (2) · Edward S Schulman, MD (1) · Gerald Predy, FFCPC (1) · Gunilla Hedlin, Prof. Dr. (1) · Lennart Nordvall, Prof. Dr (1) · Liza O'Dowd, MD (1) · Noel E Cranswick, Prof. Dr. (1) · Peter Le Souef, Prof. Dr. (1) · Shaile Shah, MD (1) · Stefan Zielen, Prof. Dr. (1) · Ulrich Wahn, Prof. Dr. (1)
2009 (1)